(Q41686298)

7 October 2017

title

A prognostic analysis of 895 cases of stage III colon cancer in different colon subsites (English)

1 reference

7 October 2017

1 reference

Yan Zhang

1

1 reference

7 October 2017

Junli Ma

2

1 reference

7 October 2017

Sai Zhang

3

1 reference

7 October 2017

Ganlu Deng

4

1 reference

7 October 2017

Xiaoling Wu

5

1 reference

7 October 2017

Jingxuan He

6

1 reference

7 October 2017

Haiping Pei

7

1 reference

7 October 2017

Hong Shen

8

1 reference

7 October 2017

Shan Zeng

9

1 reference

7 October 2017

publication date

9 June 2015

1 reference

International Journal of Colorectal Disease

7 October 2017

published in

1 reference

7 October 2017

volume

30

1 reference

7 October 2017

issue

9

1 reference

7 October 2017

page(s)

1173-1183

1 reference

Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location

7 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00384-015-2273-Z

Are there two sides to colorectal cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-015-2273-Z

Colorectal cancer: a tale of two sides or a continuum?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-015-2273-Z

Two colons-two cancers: paradigm shift and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-015-2273-Z

Is there a difference in survival between right- versus left-sided colon cancers?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-015-2273-Z

Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-015-2273-Z

Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-015-2273-Z

Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-015-2273-Z

A nationwide Danish cohort study challenging the categorisation into right-sided and left-sided colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-015-2273-Z

Differential gene expression in colon cancer of the caecum versus the sigmoid and rectosigmoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-015-2273-Z

Influence of anatomical subsite on the incidence of microsatellite instability, and KRAS and BRAF mutation rates in patients with colon carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-015-2273-Z

Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-015-2273-Z

Survival After Resection of Colorectal Cancer Based on Anatomical Segment of Involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-015-2273-Z

Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-015-2273-Z

Adjuvant therapies for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-015-2273-Z

FOLFOX and FLOX regimens for the adjuvant treatment of resected stage II and III colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-015-2273-Z

Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-015-2273-Z

Platinum resistance: the role of DNA repair pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-015-2273-Z

Nucleotide excision repair and anti-cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-015-2273-Z

Molecular mechanisms of resistance and toxicity associated with platinating agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-015-2273-Z

Determinants of chemosensitivity in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-015-2273-Z

ERCC1 and BRAC1 mRNA expression levels in the primary tumor could predict the effectiveness of the second-line cisplatin-based chemotherapy in pretreated patients with metastatic non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-015-2273-Z

Combination of TRAP1 and ERCC1 Expression Predicts Clinical Outcomes in Metastatic Colorectal Cancer Treated with Oxaliplatin/5-Fluorouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-015-2273-Z

ERCC1, defective mismatch repair status as predictive biomarkers of survival for stage III colon cancer patients receiving oxaliplatin-based adjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-015-2273-Z

Predictive value of ERCC1, ERCC2, and XRCC1 overexpression for stage III colorectal cancer patients receiving FOLFOX-4 adjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-015-2273-Z

Thymidylate synthase expression in colorectal cancer: a prognostic and predictive marker of benefit from adjuvant fluorouracil-based chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-015-2273-Z

Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-015-2273-Z

Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-015-2273-Z

DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-015-2273-Z

Tumor subsite location within the colon is prognostic for survival after colon cancer diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-015-2273-Z

Comparison of 17,641 patients with right- and left-sided colon cancer: differences in epidemiology, perioperative course, histology, and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-015-2273-Z

Prognostic impact of tumor location in stage IV colon cancer: a propensity score analysis in a multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-015-2273-Z

Survival for colon and rectal cancer in a population-based cancer registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-015-2273-Z

Association between ERCC1 and TS mRNA levels and disease free survival in colorectal cancer patients receiving oxaliplatin and fluorouracil (5-FU) adjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-015-2273-Z

Lack of correlation between thymidylate synthase levels in primary colorectal tumours and subsequent response to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-015-2273-Z

Differences between right- and left-sided colon cancer in patient characteristics, cancer morphology and histology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-015-2273-Z

Distinct molecular patterns based on proximal and distal sporadic colorectal cancer: arguments for different mechanisms in the tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-015-2273-Z

Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-015-2273-Z

BRAF-mutated, microsatellite-stable adenocarcinoma of the proximal colon: an aggressive adenocarcinoma with poor survival, mucinous differentiation, and adverse morphologic features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-015-2273-Z

BRAF mutations in colorectal cancer are associated with distinct clinical characteristics and worse prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-015-2273-Z

Loss of Rb1 in the gastrointestinal tract of Apc1638N mice promotes tumors of the cecum and proximal colon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-015-2273-Z

Cellular and molecular pharmacology of oxaliplatin.

21 January 2018

1 reference

12 December 2020

Impact of tumor location on nodal evaluation for colon cancer

1 reference

12 December 2020

Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil

1 reference

12 December 2020

TS and DPD mRNA levels on formalin-fixed paraffin-embedded specimens as predictors for distant recurrence of rectal cancer treated with preoperative chemoradiotherapy

1 reference

12 December 2020

Impact of the expression of thymidylate synthase and dihydropyrimidine dehydrogenase genes on survival in stage II/III gastric cancer

1 reference

12 December 2020

[Site-specific colorectal cancer; how is it different?]

1 reference

12 December 2020

Two colons--two cancers? Proximal or distal adenocarcinoma: arguments for a different carcinogenesis

1 reference

12 December 2020

Distinguishing right from left colon by the pattern of gene expression

1 reference

12 December 2020

Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression levels: predictors for survival in colorectal cancer patients receiving adjuvant 5-fluorouracil

1 reference

12 December 2020

Thymidylate synthase and p53 expression in primary tumor do not predict chemotherapy outcome in metastatic colorectal carcinoma

1 reference

12 December 2020

Thymidylate synthase protein expression in primary colorectal cancer compared with the corresponding distant metastases and relationship with the clinical response to 5-fluorouracil

1 reference

12 December 2020

Aberrant expression of pRb and p16(INK4), alone or in combination, indicates poor outcome after resection in patients with colorectal carcinoma

1 reference

12 December 2020

Thymidylate synthetase - a target enzyme in cancer chemotherapy

1 reference

12 December 2020

[The Relationship between the efficacy of mFOLFOX6 treatment and the expression of TS, DPD, TP, and ERCC-1 in unresectable colorectal cancer]

1 reference

12 December 2020

Comparative proteomic study for profiling differentially expressed proteins between Chinese left- and right-sided colon cancers

1 reference

12 December 2020

The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer

1 reference

12 December 2020

10.1007/S00384-015-2273-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

7 October 2017

1003288608

0 references

1 reference